6 completed, 1 terminated. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 4 |
Follow Yuria-Pharm: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Postmarketing Multicenter Study of Intra-Articular DIART ONE / EASYGO ONE for Knee Osteoarthritis Knee Osteoarthritis, Osteoarthritis of the Knee | Completed | Yuria-Pharm | 55 | 2021-08-14 | 2025-04-15 | |
| Epidemiological Study of the COVID-2019 in Participating Organizations. ELISA test for the antibodies to COVID-2019. - Covid19 | Completed | Yuria-Pharm | 3632 | 2021-03-16 | 2021-10-01 | |
| Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Peritonitis Rheosorbilact®, Ringer lactate - Peritonitis, Intoxication | Phase 4 | Completed | Yuria-Pharm | 180 | 2018-01-10 | 2020-02-21 |
| Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Pneumonia Rheosorbilact®, Ringer lactate - Pneumonia | Phase 4 | Completed | Yuria-Pharm | 150 | 2018-01-08 | 2020-02-18 |
| Efficacy and Safety of Intravenous Treatment of Tuberculosis Isoniazid, Rifampicin, Ethambutol - Tuberculosis, Pulmonary | Terminated | Yuria-Pharm | 166 | 2017-03-03 | 2019-11-07 | |
| Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Burns Rheosorbilact®, Ringer lactate - Burns, Intoxication | Phase 4 | Completed | Yuria-Pharm | 118 | 2017-02-02 | 2025-03-10 |
| Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Sepsis. Rheosorbilact®, Ringer lactate - Sepsis, Intoxication; Septic | Phase 4 | Completed | Yuria-Pharm | 180 | 2016-12-06 | 2020-02-21 |
Arthralgia (1) · Burns (1) · COVID-19 (1) · Joint Diseases (1) · Osteoarthritis, Knee (1) · Peritonitis (1) · Pneumonia (1) · Sepsis (1) · Toxemia (1) · Tuberculosis, Pulmonary (1)
Ringer's Lactate (4) · Ethambutol (1) · Isoniazid (1) · Rifampin (1) · Solutions (1) · Tablets (1)
Ukraine (7) · Moldova (4) · Uzbekistan (4) · Georgia (3) · Kazakhstan (3) · Vietnam (1)